INFO & CONTACTS:  +39 02 2390 1

Data Science

Milano
Via Giacomo Venezian, 1, 20133 Milano MI

Paolo Verderio

Dr. Verderio Paolo

Head

Typology: Research Area, Complex Structure

It combines the skills of Bio-Informaticians, Statisticians, Data Scientists, Medical Physicists, Biomedical Engineers, to collect, harmonize and integrate "scattered" data (epidemiological, biological, from images, clinical, pathological, from treatment) and generate computational models that interpret the biological effects of exclusive or multimodal oncology treatments and which can assist in clinical decisions at both the population and individual patient levels. 

The applied activity is carried out collaborating with the researchers of the Institute or in the context of national and international studies in the areas of diagnosis, therapy and prognosis of oncological diseases, as well as in in-vitro and in-vivo trials in the context of experimental research. This activity is accompanied by the statistical methodological commitment aimed at the development of innovative technologies and the training activity of researchers with a clinical/biological, statistical/bioinformatics or physical/engineering profile. 

Paolo Verderio, Head of Complex Structure

Luisa Emma Morandi (Secretariat)

Dott. Verderio Paolo
Head

Dott. Baili Paolo
Group Leader Researcher

Dott.ssa Rancati Tiziana
Group Leader Researcher

Dott. Cicchetti Alessandro
Healthcare Researcher

Ricercatori Sanitari Junior 

Catalano Alessandra 

Gioscio Eliana 

Iacovacci Jacopo 

Possenti Luca 

 

Borsisti  

Armanini Justin 

Dionisi Ferrera Benedetta 

Longhi Enrico

Tartaro Sofia 

 

Personale di supporto alla ricerca  

Bonfarnuzzo Simone 

Lillini Roberto 

Cavallo Ilaria (Direzione Scientifica

Pisani Francesco  (collaborazione professionale

 

Personale amministrativo  

Morandi Luisa Emma 

Bioinformatics and Biostatistics

Biostatistics for Clinical Research

Causal Inference for radiotherapy

Digital twins for radiotherapy

Identification of quantitative factors and support tools to reduce the risk of adverse events after oncological treatments

maging biomarkers for treatment response

Microenvironment-on-chip for chemo-radiotherapy testing

MRI Imaging for Active Surveillance in Prostate Cancer

The effect of the microbiota on the efficacy and side effects of radiotherapy

Toolkit for Radiotherapy Data Quality Assurance and Dosimetric Metrics

European Reference Network on Rare Adult Solid Cancers "EURACAN": entering phase II - EURACAN23-27

Intelligent Ecosystem to improve the governance, the sharing and the re-use of health Data for Rare Cancers - IDEA4RC

Last update: 09/06/2025

Subscribe to the newsletter

Sign up for our newsletter to stay informed about news, events, and updates from the Institute

Subscribe